Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Amengual

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Rheumatology International|November 18, 2020
COVID-19 pandemic in JapanOlga Amengual, Tatsuya Atsumi
Modern Rheumatology|February 2, 2018
Antiphospholipid syndrome, "the best prophet of the future"Olga Amengual, Tatsuya Atsumi
European Journal of Rheumatology|November 23, 2020
New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndromeYuichiro Fujieda, Olga Amengual
Modern Rheumatology|April 12, 2017
Current trends in medical English education and the Japan College of Rheumatology International SchoolEric Hajime Jego, Olga Amengual
Immunological Medicine|February 29, 2020
B cells targeting therapy in the management of systemic lupus erythematosusWen Shi Lee, Olga Amengual
Current Vascular Pharmacology|June 23, 2011
Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndromeOlga Amengual, Tatsuya Atsumi, Takao Koike
Clinical Immunology (Orlando, Fla.)|July 9, 2004
Antiprothombin antibodies and the diagnosis of antiphospholipid syndromeOlga Amengual, Tatsuya Atsumi, Takao Koike
European Journal of Clinical Investigation|July 13, 2012
Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndromeKenji Oku, Olga Amengual, Tatsuya Atsumi
Current Rheumatology Reports|July 26, 2017
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated ScoresKenji Oku, Olga Amengual, Shinsuke Yasuda, et al.
Seminars in Thrombosis and Hemostasis|September 25, 2008
Antiprothrombin antibody testing: detection and clinical utilityKenji Oku, Tatsuya Atsumi, Olga Amengual, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Rheumatology International|November 18, 2020
COVID-19 pandemic in JapanOlga Amengual, Tatsuya Atsumi
Modern Rheumatology|February 2, 2018
Antiphospholipid syndrome, "the best prophet of the future"Olga Amengual, Tatsuya Atsumi
European Journal of Rheumatology|November 23, 2020
New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndromeYuichiro Fujieda, Olga Amengual
Modern Rheumatology|April 12, 2017
Current trends in medical English education and the Japan College of Rheumatology International SchoolEric Hajime Jego, Olga Amengual
Immunological Medicine|February 29, 2020
B cells targeting therapy in the management of systemic lupus erythematosusWen Shi Lee, Olga Amengual
Current Vascular Pharmacology|June 23, 2011
Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndromeOlga Amengual, Tatsuya Atsumi, Takao Koike
Clinical Immunology (Orlando, Fla.)|July 9, 2004
Antiprothombin antibodies and the diagnosis of antiphospholipid syndromeOlga Amengual, Tatsuya Atsumi, Takao Koike
European Journal of Clinical Investigation|July 13, 2012
Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndromeKenji Oku, Olga Amengual, Tatsuya Atsumi
Current Rheumatology Reports|July 26, 2017
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated ScoresKenji Oku, Olga Amengual, Shinsuke Yasuda, et al.
Seminars in Thrombosis and Hemostasis|September 25, 2008
Antiprothrombin antibody testing: detection and clinical utilityKenji Oku, Tatsuya Atsumi, Olga Amengual, et al.
Pageof 8